Mardi C. Dier
2013
In 2013, Mardi C. Dier earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals, a 124% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $147,700 |
| Option Awards | $1,127,535 |
| Salary | $340,491 |
| Other | $500 |
| Total | $1,691,226 |
Dier received $1.1M in option awards, accounting for 67% of the total pay in 2013.
Dier also received $75K in bonus, $147.7K in non-equity incentive plan, $340.5K in salary and $500 in other compensation.
Rankings
In 2013, Mardi C. Dier's compensation ranked 4,484th out of 12,286 executives tracked by ExecPay. In other words, Dier earned more than 63.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,484 out of 12,286 | 64th |
Division Manufacturing | 1,541 out of 4,612 | 67th |
Major group Chemicals And Allied Products | 440 out of 1,466 | 70th |
Industry group Drugs | 305 out of 1,160 | 74th |
Industry Pharmaceutical Preparations | 245 out of 890 | 73rd |
Source: SEC filing on April 30, 2015.
Dier's colleagues
We found two more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2013.